Table 1 Baseline clinical characteristics of the patients stratified by NR

TyG index

<0.001

TyG<8.79

704(55.13%)

138(33.99%)

TyG ≥ 8.79

573(44.87%)

268(66.01%)

SPISE index

6.92 ± 1.75

6.92 ± 1.78

0.576

Age, years

61.80 ± 10.52

67.37 ± 10.56

< 0.001

Female gender

374(29.29%)

166(40.89%)

< 0.001

BMI

24.86 ± 4.58

24.24 ± 4.08

0.056

SBP

125.32 ± 22.62

122.79 ± 23.51

0.080

DBP

76.82 ± 13.74

73.94 ± 14.14

0.002

Medical history

 Hypertension

856(67.03%)

290(71.43%)

0.098

 Dyslipidemia

567(44.40%)

155(38.18%)

0.256

Current smoking

678 (53.13%)

194 (47.78%)

0.039

 Previous CAD

249 (19.50%)

124 (30.54%)

< 0.001

Laboratory values

 WBC,109/L

10.04 ± 3.72

10.70 ± 4.33

0.032

  Neutrophil count, 109/L

40.65 ± 33.92

41.88 ± 35.09

0.261

 Lymphocyte count,109/L

10.19 ± 11.13

9.30 ± 10.34

0.157

 Monocyte count,109/L

3.34 ± 3.38

3.63 ± 3.72

0.140

 Hemoglobin, g/L

109.64 ± 58.25

89.11 ± 58.87

< 0.001

 Platelet count,109/L

221.60 ± 64.25

223.63 ± 76.07

0.598

 HbA1c, %

8.13 ± 1.80

8.15 ± 1.80

0.829

 Creatinine, umol/L

76.95 ± 41.69

105.72 ± 102.85

< 0.001

 eGFR,ml/min/1.73m2

94.84 ± 38.86

71.45 ± 35.65

< 0.001

 TG, mmol/L

2.03 ± 1.58

2.47 ± 1.39

< 0.001

 TC, mmol/L

4.05 ± 1.06

3.96 ± 0.96

0.725

 LDL-C, mmol/L

2.14 ± 0.75

2.16 ± 0.88

0.628

 HDL-C, mmol/L

0.88 ± 0.22

0.90 ± 0.26

0.439

 FPG, mmol/L

11.09 ± 4.77

12.65 ± 5.60

< 0.001

Echocardiography

LVEF,%

52.50 ± 10.27

46.99 ± 12.44

< 0.001

AMI

0.348

 STEMI

922 (72.20%)

288 (70.94%)

 NSTEMI

355 (27.80%)

118 (29.06%)

Angiographic characteristics

Initial TIMI

<0.01

 0

615 (48.16%)

367 (90.39%)

 1

71 (5.56%)

6 (1.48%)

 2

137 (10.73%)

9 (2.22%)

 3

454 (35.55%)

24 (5.91%)

Thrombus aspiration

81 (6.34%)

14 (3.45%)

0.028

Infarction related artery

 LM

13 (1.02%)

1 (0.25%)

0.136

 LAD

604 (47.30%)

44 (10.84%)

< 0.001

 RCA

483 (37.82%)

301 (74.14%)

< 0.001

 LCX

190 (14.88%)

61 (15.02%)

0.943

Number of stents

1.35 ± 0.68

1.13 ± 0.43

0.243

Stent diameter, mm

3.05 ± 0.45

3.28 ± 0.46

0.183

Stent length, mm

26.88 ± 8.12

28.81 ± 7.92

0.164

IABP

28 (2.19%)

4 (0.99%)

0.121

Calcifying lesion

29 (2.27%)

5 (1.23%)

0.195

Treatments

 Aspirin

1275 (99.84%)

404 (99.51%)

0.247

 Ticagrelor

653 (51.14%)

210 (51.72%)

0.836

 Clopidogrel

622 (48.71%)

196 (48.28%)

0.218

 Beta-blocker

981 (76.82%)

311 (76.60%)

0.927

 Statin

1267 (99.22%)

386 (95.07%)

< 0.001

 ACEI/ARB

635 (49.73%)

200 (49.26%)

0.223